Sentences with phrase «investors in the pharmaceutical company»

In this class action insider trading case, Pomerantz, as Co-Lead Counsel, achieved a $ 135 million settlement for investors in the pharmaceutical company Elan Corp..

Not exact matches

Activist hedge fund investor and recent Valeant Pharmaceuticals (vrx) board appointee Bill Ackman on Wednesday slammed the company's steep drug price hikes in testimony before the U.S. Senate Special Committee on Aging, going so far as to say the cost bumps «contributed to healthcare inflation and called into question the company's commitment to the patients it serves.»
The investors are frustrated that shares in Jazz, a $ 9 billion pharmaceutical company known for its narcolepsy drug Xyrem, have remained essentially flat over the past year.
Pomerantz is co-lead counsel in a securities class action against international pharmaceutical company Perrigo plc concerning allegations related to the company misleading investors as to its revenue growth potential in order to encourage them to reject a tender offer by Mylan N.V.
He represents pharmaceutical companies both large and small on a myriad of issues, as well as several universities in both patenting and licensing to outside investors.
Art has over 30 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies.
«We are pleased to share this vision with the unique blend of crossover funds, pharmaceutical companies, and venture capital investors participating in our Series B, and look forward to advancing our position as the leading biotech with a dual focus on synthetic lethality and immuno - oncology.»
The FDA is relevant for investors specifically in regards to biotech and pharmaceutical companies.
In healthcare, Pfizer and other pharmaceutical companies have lined up one - off funding for the development of specific products, matching their capital needs with the risk preferences and expertise of individual investors.
Some investors argue that massive share - price increases in 2014 mean that even future successes won't produce strong returns for shareholders buying in at today's prices, but the demand among top pharmaceutical companies for promising drug candidates to add to their pipelines shows few signs of slowing anytime soon, and that could bode well for the sector in the coming year.
Among some of the major homegrown companies that Enterprise Investors assisted and that went public on the WSE were the First Polish - American Bank in 1994, pharmaceuticals company Polfa Kutno in 1995 and packaging manufacturer Grupa Kęty in 1996.
Now, in the IMS Health case, a big part of explaining why investors might take such a deal is that it offered a nice premium over the recent stock price and they might have been comparing IMS Health to pharmaceutical companies (IMS Health's customers) instead of pharmaceutical services companies (IMS Health's peers).
The so - called «Pharma Bro,» notorious for raising the price of a potentially life - saving drug by 5,000 percent, was found guilty today of defrauding investors in two hedge funds and in Retrophin Inc., a pharmaceutical company he co-founded.
In a sign of the growing enthusiasm for the field, in March GRAIL, a company spun off from Illumina, raised $ 900 million in funding for this last application from investors including Amazon and several major pharmaceutical companieIn a sign of the growing enthusiasm for the field, in March GRAIL, a company spun off from Illumina, raised $ 900 million in funding for this last application from investors including Amazon and several major pharmaceutical companiein March GRAIL, a company spun off from Illumina, raised $ 900 million in funding for this last application from investors including Amazon and several major pharmaceutical companiein funding for this last application from investors including Amazon and several major pharmaceutical companies.
Art has over 30 years of operating experience as a pharmaceutical and biotechnology industry executive, and venture capital investor in life science companies.
The Vanguard Health Care Fund Investor Shares (VGHCX) offers investors low - cost exposure to domestic and foreign companies involved in various aspects of the health care industry, such as pharmaceutical firms, medical supply companies and research firms.
In a separate letter to the Corporate Secretary of the Company, the Investor is simultaneously submitting a Stockholder's Notice of Nomination of Persons for Election as Directors and Other Proposed Business at the 2009 Annual Meeting of Stockholders of Vanda Pharmaceuticals Inc., dated February 13, 2009 (the «Notice»).
Which has its pros & cons: Investors mostly adjust accordingly (i.e. reverse out some / all of this intangible expense), which explains why intellectual property companies (as in technology, media, pharmaceuticals, etc.) often trade on steep earnings multiples vs. the rest of the market.
Investor documents from the company that makes Nuedexta, Avanir Pharmaceuticals, indicate that only a small percentage of people with PBA reside in long - term care facilities.
acted as counsel and advocate for a Chinese pharmaceutical company in HKIAC proceedings seated in Hong Kong arising from a dispute with a foreign investor
Mr. Girard currently serves on the leadership team in the Target and Sony data breach actions; serves as lead counsel in derivative litigation on behalf of Wal - Mart shareholders arising out of alleged bribery in Mexico, lead counsel for commodities investors in litigation arising out of the collapse of a commodities futures merchant, and lead counsel in a multi-district «pay for delay» antitrust proceeding against major pharmaceutical companies.
The reports also indicate that investors are in fact buying Galaxy Digital's shares through a shell pharmaceutical company which will allow Novogratz's firm to be listed on a Canadian stock exchange without disclosing its financials.
a b c d e f g h i j k l m n o p q r s t u v w x y z